Feldan Travel ltd

Start Date End Date Funded Value Relevance

CSV

25 50 100

£435,489

Feb 13 - Sep 14

To benchmark the utility of E06: A half-life extension, single-domain, shark antibody bio-tool, and progress it to a Phase 1 ready candidate clone

BBSRC award to University of Aberdeen and Andrew Porter

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}